Nuveen Asset Management, LLC Synlogic, Inc. Transaction History

Nuveen Asset Management, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2020 Aug 14, 2020	SELL	$1.59 - $2.51 $89,989 - $142,058	-56,597 Closed	0 $0
Q1 2020 May 14, 2020	BUY	$1.39 - $3.19 $8,497 - $19,500	6,113 Added 12.11%	56,597 $97,000
Q4 2019 Feb 14, 2020	SELL	$1.96 - $2.81 $59,442 - $85,221	-30,328 Reduced 37.53%	50,484 $130,000
Q3 2019 Nov 14, 2019	BUY	$2.12 - $9.37 $51,753 - $228,740	24,412 Added 43.28%	80,812 $186,000
Q2 2019 Aug 15, 2019	BUY	$6.27 - $9.48 $353,628 - $534,672	56,400 New	56,400 $513,000

25.5K

Ticker SYBX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 70,229,600
Market Cap $103M
Description
Synlogic, Inc., a clinical-stage biopharmaceutical company, engages in the discovery and development of synthetic biotic medicines to treat metabolic and immunological diseases in the United States. Its therapeutic programs include SYNB1618 and SYNB1934 that are orally administered, non-systemically absorbed drug candidates, which are in Phase I...

Get notified when there are updates to the investment portfolio of Nuveen Asset Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Nuveen Asset Management, LLC with notifications on news.